-
Turn Therapeutics gets authorisation for Covid-19 therapeutic candidate trial
pharmaceutical-technology
January 25, 2021
Biotechnology company Turn Therapeutics has received authorisation in Panama to begin the human trial of its product, Hexagen, for treating Covid-19.
-
Natural remedies, Immunofree and Reginmune show great response against COVID-19 in clinical trial
expresspharma
January 25, 2021
Reportedly, these medicines were found to work better in a comparative clinical trial than the existing standard of care.
-
AI to be most disruptive technology across pharma industry in 2021 and beyond
expresspharma
January 25, 2021
GlobalData analysis shows that while four partnerships were forged between AI vendors and large pharma companies in 2015, they rose to 27 by 2020, an increase of 575 per cent in just six years.
-
Zydus’ Desidustat efficacious in treating hypoxia in Mexico’s hospitalised COVID-19 patients: Study
expresspharma
January 25, 2021
None of the hospitalised patients required mechanical ventilator in the Desidustat arm, while 25 per cent patients on the standard of care arm required mechanical ventilator.
-
Obesity, impaired metabolic health and COVID-19
worldpharmanews
January 22, 2021
In a Nature Reviews Endocrinology article authors from the German Center for Diabetes Research (DZD) highlight the interconnection of obesity and impaired metabolic health with the severity of COVID-19.
-
Obesity, impaired metabolic health and COVID-19
worldpharmanews
January 22, 2021
In a Nature Reviews Endocrinology article authors from the German Center for Diabetes Research (DZD) highlight the interconnection of obesity and impaired metabolic health with the severity of COVID-19.
-
Phase II trial to establish whether alisporivir can prevent COVID-19 progression
europeanpharmaceuticalreview
January 22, 2021
The trial will primarily assess whether alisporivir (Debio 025) can significantly reduce COVID-19 viral load in hospitalised COVID-19 patients with moderate symptoms.
-
Clinical microbiology to play key role in COVID-19 response, report says
europeanpharmaceuticalreview
January 22, 2021
New research has said that clinical microbiology is critical to understanding COVID-19, with laboratories studying the coronavirus globally.
-
Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for Patients with Severe COVID-19
prnasia
January 22, 2021
Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that the first patient has enrolled into an investigator-initiated ...
-
eMed? Announces Partnership with the State of Ohio to Provide Millions of BinaxNOW? At-Home COVID-19 Rapid Tests
prnewswire
January 22, 2021
eMed? announced a partnership with the State of Ohio to distribute and administer at least 2 million virtually-guided, BinaxNOW? at-home COVID-19 rapid tests, which deliver results within minutes.